(Q41640800)

English

Interferon- α can alter the Lytic Susceptibility of Murine Bladder Transitional Cell Carcinoma (MBT-2) by their Original Poor Specific Cytotoxic Tumor Infiltrating Lymphocytes

scientific article published on February 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 October 2017

Interferon- α can alter the Lytic Susceptibility of Murine Bladder Transitional Cell Carcinoma (MBT-2) by their Original Poor Specific Cytotoxic Tumor Infiltrating Lymphocytes (English)

reason for preferred rank

most precise value

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Interferon-alpha can alter the lytic susceptibility of murine bladder transitional cell carcinoma (MBT-2) by their original poor specific cytotoxic tumor infiltrating lymphocytes (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732635

11 November 2022

transitional cell carcinoma

1 reference

based on heuristic

inferred from title

immunologic cytotoxicity

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732635

11 November 2022

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

author name string

T. S. Tzai

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732635

11 November 2022

S. N. Lin

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732635

11 November 2022

language of work or name

0 references

publication date

1 February 1992

1 reference

Europe PubMed Central

5 October 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0022534717372932?httpAccept=text/xml

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

https://api.elsevier.com/content/article/PII:S0022534717372932?httpAccept=text/plain

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2937293-2

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Journal of Urology

1 reference

Europe PubMed Central

5 October 2017

147

1 reference

Europe PubMed Central

5 October 2017

2

1 reference

Europe PubMed Central

5 October 2017

523-527

1 reference

Europe PubMed Central

5 October 2017

Prognostic significance of microscopic structure of gastric carcinomas and their regional lymph nodes

1

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

3

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Activation of human tumor-infiltrating lymphocytes by monoclonal antibodies directed to the CD3 complex

4

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

5

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Effects of murine tumor class I major histocompatibility complex expression on antitumor activity of tumor-infiltrating lymphocytes

7

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer

8

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies

9

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Augmented tumor-associated antigen expression by interferons

10

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo

11

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Suppressive immunoregulatory factors produced by tumors

12

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

The role of class I histocompatibility antigens in the regulation of T-cell activation

13

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection

14

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Interleukin 2 suppression of a murine bladder cancer implanted into kidney, bladder and skin; its organ specificity

16

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes

17

1 reference

10.1016/S0022-5347(17)37293-2

https://api.crossref.org/works/10.1016/S0022-5347(17)37293-2

11 November 2022

Identifiers

10.1016/S0022-5347(17)37293-2

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1732635

11 November 2022

1 reference

Europe PubMed Central

5 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41640800&oldid=1769031209"